LONDON/PARIS - Britain has signed a deal for up to 60 million doses of a potential coronavirus vaccine being developed by Sanofi and GlaxoSmithKline , it said on Wednesday, its latest such arrangement as the race to tame the pandemic heats up.
But with no vaccine yet proven to work, a range of potential suppliers is seen as giving the best chance of success."It is important that we secure early access to a diverse range of promising vaccine candidates ... to increase our chances of finding one that works." Asked about the price, GSK CEO Emma Walmsley said only that GSK did not expect to profit from the product during the pandemic and any short-term earnings would be partly be reinvested into pandemic preparedness and donated to developing countries. [L3N2F038V]
Last week, Britain struck deals for 30 million doses of an experimental BioNtech/Pfizer vaccine, and a deal in principle for 60 million doses of Valneva's potential shot, which followed a previously announced deal for 100 million doses of an experimental Oxford/AstraZeneca vaccine.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Britain signs supply deal for 60 million doses of Sanofi/GSK Covid-19 vaccineLONDON/PARIS (REUTERS) - Britain has signed a supply deal for up to 60 million doses of a possible Covid-19 vaccine being developed by Sanofi and GlaxoSmithKline , it said on Wednesday (July 29), its fourth such arrangement.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »
MAS calls on local banks to cap this year's dividends at 60% of previous year'sTHE Monetary Authority of Singapore (MAS) on Wednesday has called on local banks to cap their total dividends per share (DPS) for FY2020 at 60 per cent of the amount in the previous financial year, in a move to shore up capital amid the uncertain economic climate. Read more at The Business Times.
Source: BusinessTimes - 🏆 15. / 51 Read more »
Britain signs supply deal for 60 million doses of Sanofi/GSK Covid-19 vaccineLONDON/PARIS (REUTERS) - Britain has signed a supply deal for up to 60 million doses of a possible Covid-19 vaccine being developed by Sanofi and GlaxoSmithKline , it said on Wednesday (July 29), its fourth such arrangement.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »
Moderna pitches coronavirus vaccine at around US$50-US$60 per course: Financial TimesWASHINGTON (REUTERS) - Moderna Inc is planning to price its coronavirus vaccine at US$50 to US$60 (S$69 to S$83) per course - higher than other vaccine makers have agreed to charge governments, the Financial Times reported on Tuesday (July 28), citing sources familiar with the matter.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »
COVID-19 vaccine unlikely to be widely available before mid-2021, says GermanyGerman Research Minister Anja Karliczek said on Wednesday that a coronavirus vaccine was unlikely to be widely available before the middle of next ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »